Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6403.5000 -5.00 (-0.08%)
NSE Mar 02, 2026 15:31 PM
Volume: 300.3K
 

6403.50
-0.08%
BOB Capital Markets Ltd.
Q3 sales/EBITDA/PAT were 0.6%/7.5%/22.3% above our estimates. PAT was higher than estimated due to the adoption of the new tax regime
Divi's Laboratories .. has an average target of 6444.67 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended